by telrheum | Apr 6, 2024 | Vasculitis, Biologic Therapy, Remove term: eosinophilic granulomatosis with polyangiitis eosinophilic granulomatosis with polyangiitis
The MANDARA study explored how effective and safe benralizumab is compared to mepolizumab for treating Eosinophilic Granulomatosis with Polyangiitis (EGPA), a condition that typically requires long-term treatment with oral glucocorticoids and immunosuppressants. This...
by telrheum | Apr 6, 2024 | Biologic Therapy, Rheumatoid Arthritis, tumour necrosis factor inhibitors (TNFis)
This study, conducted by researchers from Yonsei University College of Medicine in South Korea, investigated the risk of cardiovascular events like heart attacks or strokes in patients with ankylosing spondylitis (AS), a type of arthritis affecting the spine. They...
by telrheum | Apr 6, 2024 | Biologic Therapy, Sjögren’s Syndrome
Dazodalibep (DAZ) is a special type of protein used to treat Sjögren’s disease, which affects the immune system. In a study, patients with this disease took DAZ or a placebo (a treatment with no active drug) to see how effective and safe DAZ is. The study was...
by telrheum | Apr 6, 2024 | Biologic Therapy, Rheumatic Drugs, Rheumatoid Arthritis
The ARCTIC REWIND study explored the long-term effects of reducing and stopping tumor necrosis factor inhibitor (TNFi) treatment in patients with rheumatoid arthritis (RA) who were in sustained remission. The study involved randomly assigning patients who had been in...
by telrheum | Apr 1, 2024 | Magnetic Resonance Imaging, Rheumatoid Arthritis, Uncategorized
The study explored the effectiveness and safety of auricular vagus nerve stimulation (VNS) in treating rheumatoid arthritis (RA). Earlier small or uncontrolled studies suggested VNS could reduce RA symptoms. In this larger, controlled trial, participants with active...